Covenant Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $245K | Sell |
|
|||||
|
2024
Q4 | $640K | Sell |
|
|||||
|
2024
Q3 | $6.67M | Sell |
|
|||||
|
2024
Q2 | $6.67M | Sell |
|
|||||
|
2024
Q1 | $6.12M | Sell |
|
|||||
|
2023
Q4 | $5.59M | Buy |
|
|||||
|
2023
Q3 | $5.06M | Buy |
|
|||||
|
2023
Q2 | $3.02M | Buy |
|
|||||
|
2023
Q1 | $329K | Hold |
|
|||||
|
2022
Q4 | $289K | Sell |
|
|||||
|
2022
Q3 | $3.93M | Buy |
|
|||||
|
2022
Q2 | $5.02M | Sell |
|
|||||
|
2022
Q1 | $8.1M | Sell |
|
|||||
|
2021
Q4 | $7.56M | Sell |
|
|||||
|
2021
Q3 | $7.25M | Buy |
|
|||||
|
2021
Q2 | $6.58M | Buy |
|
|||||
|
2021
Q1 | $459K | Hold |
|
|||||
|
2020
Q4 | $469K | Hold |
|
|||||
|
2020
Q3 | $544K | Hold |
|
|||||
|
2020
Q2 | $606K | Sell |
|
|||||
|
2020
Q1 | $638K | Hold |
|
|||||
|
2019
Q4 | $490K | Sell |
|
|||||
|
2019
Q3 | $369K | Sell |
|
|||||
|
2019
Q2 | $490K | Sell |
|
|||||
|
2019
Q1 | $693K | Buy |
|
|||||
|
2018
Q4 | $362K | Hold |
|
|||||
|
2018
Q3 | $362K | Sell |
|
|||||
|
2018
Q2 | $317K | Sell |
|
|||||
|
2018
Q1 | $333K | Sell |
|
|||||
|
2017
Q4 | $1.49M | Sell |
|
|||||
|
2017
Q3 | $1.8M | Buy |
|
|||||
|
2017
Q2 | $1.98M | Sell |
|
|||||
|
2017
Q1 | $1.57M | Sell |
|
|||||
|
2016
Q4 | $1.97M | Buy |
|